Stephen Andrew Ashford

Dr. Stephen Andrew Ashford

Palliative Care, Policy & Rehabilitation, King's College London, London, City of London, UK
orcid
Associate Professor and Consultant Physiotherapist, London N...

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Journal of Rehabilitation Medicine
Verified
Journal Article
Open access
Stephen Andrew AshfordStephen Andrew Ashford
Stephen Andrew Ashford
MSMike Slade
Mike Slade
FMF Malaprade
F Malaprade
LTLynne Turner-Stokes
Lynne Turner-Stokes
Journal of Rehabilitation Medicine is an international peer-review journal published in English, with at least 10 issues published per year.

9 March 2006 in Physiotherapy Research International
Verified
Journal Article
Closed access
PDF file
Stephen Andrew AshfordStephen Andrew Ashford
Stephen Andrew Ashford
LTLynne Turner-Stokes
Lynne Turner-Stokes

1 January 2021 in Journal of Central Nervous System Disease
Verified
Journal Article
Open access
PDF file
GBGANESH BAVIKATTE
GANESH BAVIKATTE
GSGanesh Subramanian
Ganesh Subramanian
Stephen Andrew AshfordStephen Andrew Ashford
Stephen Andrew Ashford
RARhoda Allison
Rhoda Allison
DHDawn Hicklin
Dawn Hicklin
Stroke patients with spasticity usually require long-lasting care and interventions but frequently report that outpatient and community treatment is limited, reflecting a significant unmet need in health and social care provision. Rehabilitation and spasticity management services are essential for patient recovery, with improvements in both activity and participation reducing the burden on patients, family and society. Current clinical guidance provides scope for improvements in both post-stroke management and spasticity prevention. However, access to specialist services can be limited and the patient journey does not always match national recommendations. Identification of spasticity and its predictors and lack of subsequent referral to rehabilitation or specialist spasticity services are key issues in the management of post-stroke spasticity. Implementation of a traffic light classification system prioritises patients at an increased risk of spasticity and promotes early and consistent management across the spectrum of primary and secondary care. The proposed system is based on clinical evidence, expert consensus and recent clinical guidelines. It provides simple and straightforward criteria for management, multidisciplinary consultation and referral to specialist spasticity services, with patients allocated by monitoring requirements and a low (green/periodic monitoring), medium (amber/routine referral) or high risk (red/urgent referral) of spasticity.

2 May 2015 in International Journal of Therapy and Rehabilitation
Verified
Journal Article
Closed access
LTLynne Turner-Stokes
Lynne Turner-Stokes
HRHilary Rose
Hilary Rose
Stephen Andrew AshfordStephen Andrew Ashford
Stephen Andrew Ashford
BSBarbara Singer
Barbara Singer

1 June 2018 in European Journal of Physical and Rehabilitation Medicine
Verified
Journal Article
Closed access
LTLynne Turner-Stokes
Lynne Turner-Stokes
Stephen Andrew AshfordStephen Andrew Ashford
Stephen Andrew Ashford
AEAlberto Esquenazi
Alberto Esquenazi
JWJörg Wissel
Jörg Wissel
AWAnthony B. Ward
Anthony B. Ward
DSDavid M. Simpson
David M. Simpson
Spastic paresis is a common feature of an upper motor neuron impairment caused by stroke, brain injury, multiple sclerosis and other central nervous system (CNS) disorders. Existing national and international guidelines for the treatment of adult spastic paresis tend to focus on the treatment of muscle overactivity rather than the comprehensive approach to care, which may require life-long management. Person-centered care is increasingly adopted by healthcare systems in a shift of focus from "disease-oriented" towards "person-centered" medicine. The challenge is to apply this principle to the complex management of spastic paresis and to include an educative process that engages care providers and patients and encourages them to participate actively in the long-term management of their own disease. To address this issue, a group of 13 international clinicians and researchers used a pragmatic top-down methodology to evaluate the evidence and to formulate and grade the strength of recommendations for applying the principles of person-centered care to the management of spastic paresis. There is a distinct lack of clinical trial evidence regarding the application of person-centered medicine to the rehabilitation setting. However, the current evidence base supports the need to ensure that treatment interventions for spastic paresis should be centered on as far as reasonable on the patient's own priorities for treatment. Goal setting, negotiation and formal recording of agreed SMART goals should be an integral part of all spasticity management programs, and goal attainment scaling should be recorded alongside other standardized measures in the evaluation of outcome. When planning interventions for spastic paresis, the team should consider the patient and their family's capacity for self-rehabilitation, as well as ways to enhance this approach. Finally, the proposed intervention and treatment goals should consider the impact of any neuropsychological, cognitive and behavioral deficits on rehabilitation. These recommendations support a person-centric focus in the management of spastic paresis.

20 February 2013 in Clinical Rehabilitation
Verified
Journal Article
Closed access
Stephen Andrew AshfordStephen Andrew Ashford
Stephen Andrew Ashford
LTLynne Turner-Stokes
Lynne Turner-Stokes
RSRichard Siegert
Richard Siegert
MSMike Slade
Mike Slade
To evaluate the psychometric properties of the Arm Activity Measure (ArmA), a patient-reported measure of active and passive function in the paretic upper limb. Psychometric evaluation study. Two specialist rehabilitation and spasticity management services. Patients (n = 92) with upper limb paresis were recruited from two specialist neurorehabilitation centres. Mean age 44.5 (SD 16.7). Diagnostic distribution: stroke 48 (52%); other brain injury 28 (31%); or other neurological condition 16 (17%). Evaluation of convergent and divergent validity; unidimensionality, scaling, reliability (internal consistency and test–retest); responsiveness to change and feasibility of the ArmA were undertaken. Expected convergent and divergent relationships were seen with the Leeds Adult Spasticity Impact Scale and the Disabilities of Arm Shoulder and Hand (DASH) (rho 0.5–0.63). Principal components analysis confirmed that active and passive function formed two separate constructs in each sub-scale. Mokken analysis corroborated the findings of the principal components analysis and demonstrated scaling using the monotone homogeneity model (Item H>0.5 for all items). Cronbach’s alpha was 0.85 and 0.96, respectively, for the passive and active function subscales. Item level test–retest agreement ranged from 92-97.5% (quadratic-weighted Kappa 0.71-0.94). In the subgroup treated for spasticity with botulinum toxin (n = 58), the ArmA passive function scale identified a significant difference between responder and non-responder groups (Mann Whitney U = 0.85, p < 0.01). Respondents reported the ArmA to be relevant (77%), easy to use (90%) and timely to complete (83% under 10 minutes). The ArmA is a valid and reliable tool feasible for use in the evaluation of upper limb function in the context of treatment for spasticity.